JENNY STARK: Open Payments
NPI 1225621659 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,591 in 101 payments from 25 companies in 2025. Trend: 2023 $825 · 2024 $2,331 · 2025 $2,591
Food & beverage: $2,591
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $345 |
| UCB, Inc. | 8 | $266 |
| Teva Pharmaceuticals USA, Inc. | 8 | $227 |
| PFIZER INC. | 10 | $208 |
| ABBVIE INC. | 22 | $207 |
| SK Life Science, Inc. | 9 | $153 |
| Neurocrine BioSciences, Inc. | 2 | $146 |
| Eisai Inc. | 2 | $144 |
| Boston Scientific Corporation | 1 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
Products named: AUSTEDO XR, KISUNLA, NURTEC ODT, INGREZZA, Leqembi, Rystiggo, WATCHMAN, UBRELVY.
Industry payments across FL — which companies pay providers there.
